Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2025

Genmab — Februar 2025

Planlagt Fastgjort Låst Flyttet Genmab
699 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #504

    it is definitely easier; i think we established that long time ago. And best for the short term share price reaction. And my blood pressure... (whether JNJ would or would not sponsor the Tec or Tal , is really a
    minor issue i would think)

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #505

      New trial - eal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma / EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL) https://clinicaltrials.gov/study/NCT06830759

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #506

        Daratumumab is increasingly used in first-line, and soon patients that relapse while on daratumumab will become a common challenge.

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #507

          Link Preview Image
          ScienceDirect

          favicon

          (www.sciencedirect.com)

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #508

            Teknisk: Genmab i brud op gennem vigtige modstande, fortsætter op i USA https://proinvestor.com/investornyt/1279889/teknisk-genmab-i-brud-op-gennem-vigtige-modstande-fortsaetter-op-i-usa

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #509

              Leo Habets
              @L_Habets
              Daratumumab Seit einiger Zeit behandeln wir Post, COVID, Post Vac und MEC FS Patienten mit Daratumumab wir haben jetzt insgesamt sieben Patienten in der Behandlung https://x.com/L_Habets/status/1891069465686634514 https://x.com/L_Habets/status/1891210734530400443

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #510

                die Behandlung ist teuer, die kostet 20000€ fyr 4 gaben. Det er vist første gang, jeg har set en kontant pris på Dara.

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #511

                  TipRanks
                  Feb. 19, 2025, 01:35 AM
                  In a report released today, Emily Field from Barclays maintained a Buy rating on Genmab A/S
                  , with a price target of DKK2,100.00.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #512

                    looks like we will get an Acasunlimab Poster at the European Lung Cancer Congress at the end of the March https://cslide.ctimeetingtech.com/coasis_21204/attendee/confcal/presentation/list?q=acasunlimab Also a few for amivantamab, also orals

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #513

                      Kempen erhöht Kursziel für Genmab auf DKK 3.070 (2.950) und bekräftigt Kaufen - BN
                      Am 19. Februar 2025 https://de.marketscreener.com/kurs/aktie/GENMAB-A-S-63733191/news/Kempen-erhoht-Kursziel-fur-Genmab-auf-DKK-3-070-2-950-und-bekraftigt-Kaufen-BN-49100440/

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #514

                        Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano and Chief Development Officer Judith Klimovsky will participate in a fireside chat at the 45th Annual TD Cowen Health Care Conference, nå Winkel skal ikke med.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #515

                          Hvordan ser fremtiden ud for forsvarsaktierne i en tid med mulige milliardinvesteringer i mange lande? Hør også om Genmabs kommende og vigtige afgørelse, kollapset i Bavarian Nordic samt meget andet i afsnit 262 af Investeringspodcasten. https://proinvestor.com/boards/124824

                          1 Reply Last reply
                          0
                          • royalR Offline
                            royalR Offline
                            royal
                            wrote on sidst redigeret af
                            #516

                            Er lidt forvirret: 60 dage fra ca. 1. januar = Ultimo februar. 1. kvartal 2025 som Jan selv siger?

                            1 Reply Last reply
                            0
                            • A Offline
                              A Offline
                              Aaanditsgone
                              wrote on sidst redigeret af
                              #517

                              Hvis det er 60 arbejdsdage, passer det meget godt med slutningen af marts. Vi kender ikke den præcise deadine.

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #518

                                Shh der forhandles 😉

                                1 Reply Last reply
                                0
                                • royalR Offline
                                  royalR Offline
                                  royal
                                  wrote on sidst redigeret af
                                  #519

                                  🙂

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #520

                                    Der skal ifølge aftalen komme et svar inden 1. marts.... - Dette bekræftede Helge også forleden dag.

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Raun
                                      wrote on sidst redigeret af
                                      #521

                                      Og ja @Solsen der forhandles, med den helt store kugleramme ved bordet 😉

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #522

                                        Bemærk kursen er sluppet fri.

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #523

                                          Jep, terningerne er kastet:-)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper